In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion Pharmaceuticals insiders completed 5 transactions totaling $366,367.08. Activity included 2 stock sales and 1 tax payment, with the largest single transaction at $149,367.08. Updated 3h ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results